Sort
17,828 grants matching “crispr”
Project 4 Dissecting the Role of Revival Stem Cells and Tuft Cells in the Radiation-Induced Gastrointestinal Syndrome to Define Targets for Mitigation
$357,168David G Kirsch · Duke University · U19 · FY2023 · AI
Generation of DNA memory by bacterial CRISPR-Cas9 systems
$356,944Yan Zhang · University Of Michigan At Ann Arbor · R35 · FY2020 · GM
Elucidating the relationship between lipid droplets, oxidative lipid damage, and ferroptosis
$356,851James A Olzmann · University Of California Berkeley · R01 · FY2025 · CA
Stochastic choices in the retina and optic lobes
$356,625Claude Desplan · New York University · R01 · FY2019 · EY
Stochastic choices in the retina and optic lobes
$356,625Claude Desplan · New York University · R01 · FY2018 · EY
Stochastic choices in the retina and optic lobes
$356,625Claude Desplan · New York University · R01 · FY2017 · EY
Stochastic choices in the retina and optic lobes
$356,625Claude Desplan · New York University · R01 · FY2016 · EY
Identifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation
$356,616Michael Richard Green · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Development of a CRISPR-Cas13 Gene Therapy for SOD1-Linked ALS
$356,539Thomas Gaj · University Of Illinois At Urbana-Champaign · R01 · FY2024 · NS
Proteasome inhibitors for the treatment of solid tumors
$356,476Alexei Kisselev · Auburn University At Auburn · R01 · FY2021 · CA
Proteasome inhibitors for the treatment of solid tumors
$356,318Alexei Kisselev · Auburn University At Auburn · R01 · FY2020 · CA
Ciliary Disassembly, a modifier of Autosomal Dominant Polycystic Kidney Disease
$356,307Leonidas Tsiokas · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2021 · DK
Ciliary Disassembly, a modifier of Autosomal Dominant Polycystic Kidney Disease
$356,307Leonidas Tsiokas · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2022 · DK
Ciliary Disassembly, a modifier of Autosomal Dominant Polycystic Kidney Disease
$356,307Leonidas Tsiokas · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2023 · DK
Engineering Yeast towards High Titer Production of Monoterpene Indole Alkaloid Natural Products
$356,249Yi Tang · University Of California Los Angeles · R01 · FY2024 · AT
Development and Application of New Genome Editing Tools for the Functional Investigation of Genetic Variants of Uncertain Significance
$356,242Alexis C. Komor · University Of California, San Diego · R35 · FY2022 · GM
Development and Application of New Genome Editing Tools for the Functional Investigation of Genetic Variants of Uncertain Significance
$356,242Alexis C. Komor · University Of California, San Diego · R35 · FY2024 · GM
Development and Application of New Genome Editing Tools for the Functional Investigation of Genetic Variants of Uncertain Significance
$356,242Alexis C. Komor · University Of California, San Diego · R35 · FY2023 · GM
Replication Licensing in Genome Stability, Cancer and Aging
$356,205Erik Knudsen · Roswell Park Cancer Institute Corp · R01 · FY2019 · CA
New protein engineering-based tools and technologies for characterizing cell surface proteolysis in cancer cells for novel neo-epitope biomarkers and drug targets
$356,084James A Wells · University Of California, San Francisco · R01 · FY2023 · CA
New protein engineering-based tools and technologies for characterizing cell surface proteolysis in cancer cells for novel neo-epitope biomarkers and drug targets
$356,084James A Wells · University Of California, San Francisco · R01 · FY2022 · CA
Morphogenesis and function of somatosensory axon ensheathment by epidermal cells
$356,059Alvaro Sagasti · University Of California Los Angeles · R01 · FY2024 · AR
Morphogenesis and function of somatosensory axon ensheathment by epidermal cells
$356,059Alvaro Sagasti · University Of California Los Angeles · R01 · FY2021 · AR
Proteasome inhibitors for the treatment of solid tumors
$356,014Alexei Kisselev · Auburn University At Auburn · R01 · FY2018 · CA
The Escherichia coli Type I-E CRISPR-Cas immunity system
$355,803Joseph Thomas Wade · Wadsworth Center · R01 · FY2021 · GM